Comparison of Bruker Biotyper (R) and Vitek (R) MS matrix-assisted laserdesorption/ionization–time-of-flight massspectrometry platforms for the identificationof filamentous fungi - Supplemental Table 1
收藏tandf.figshare.com2024-05-16 更新2025-03-22 收录
下载链接:
https://tandf.figshare.com/articles/dataset/Comparison_of_Bruker_Biotyper_R_and_Vitek_R_MS_matrix-assisted_laserdesorption_ionization_time-of-flight_massspectrometry_platforms_for_the_identificationof_filamentous_fungi_-_Supplemental_Table_1/23523861/1
下载链接
链接失效反馈官方服务:
资源简介:
Aims: To evaluate the performance of twomatrix-assisted laser desorption/ionization–time-of-flight mass spectrometry platforms to identify molds isolated from clinical specimens. Methods: Fifty mold isolates were analyzed on Bruker Biotyper R ? and Vitek R ? MS platforms. Two Bruker Biotyper extraction protocols were assessed alongside the US FDA-approved extraction protocol for Vitek MS. Results: The Bruker Biotyper modified NIH-developed extraction protocol correctly identified more isolates than Bruker’s protocol (56 vs 33%). For species in the manufacturers’ databases, Vitek MS correctly identified 85% of isolates, with 8% misidentifications. The Bruker Biotyper identified 64%, with no misidentifications. For
isolates not in the databases, the Bruker Biotyper did not misidentify any, and VitekMSmisidentified 36%. Conclusion: Both the VitekMS and Bruker Biotyper accurately identified the fungal isolates, however Vitek MS was more likely to misidentify isolates than the Bruker Biotyper.
研究目的:旨在评估两种矩阵辅助激光解吸/电离-飞行时间质谱平台在识别从临床样本中分离出的霉菌方面的性能。研究方法:在Bruker Biotyper R ? 和 Vitek R ? MS平台上分析了五十个霉菌分离株。在评估美国食品药品监督管理局(US FDA)批准的Vitek MS提取方案的同时,还评估了两种Bruker Biotyper提取方案。研究结果:Bruker Biotyper改进的NIH开发提取方案正确识别的分离株数量多于Bruker的方案(56%对33%)。对于制造商数据库中的物种,Vitek MS正确识别了85%的分离株,误识别率为8%。Bruker Biotyper识别了64%,无误识别。对于数据库中未收录的分离株,Bruker Biotyper未出现误识别,而Vitek MS误识别率为36%。研究结论:Vitek MS和Bruker Biotyper均准确识别了真菌分离株,然而,与Bruker Biotyper相比,Vitek MS误识别分离株的可能性更高。
提供机构:
Taylor & Francis



